{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:18:06Z","timestamp":1790878686605,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.critrevonc.2010.01.005","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T05:10:26Z","timestamp":1264482626000},"page":"112-126","source":"Crossref","is-referenced-by-count":55,"title":["Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: The state of the art"],"prefix":"10.1016","volume":"76","author":[{"given":"Sean R.","family":"Williamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lopez-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell D.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2010.01.005_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/1097-0142(196412)17:12<1533::AID-CNCR2820171205>3.0.CO;2-7","article-title":"Natural history and clinical behavior of in situ carcinoma of the human urinary bladder","volume":"17","author":"Melamed","year":"1964","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-5347(17)68193-X","article-title":"Histological study of vesical urothelium intervening between gross neoplasms in total cytectomy","volume":"68","author":"Melicow","year":"1952","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib4","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MOU.0b013e32830b8925","article-title":"Can we still afford bladder cancer?","volume":"18","author":"Stenzl","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib6","series-title":"American joint committee on cancer staging manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib7","unstructured":"Hodges KB, Lopez-Beltran A, Davidson DD, Montironi R, Cheng L. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Hum Pathol; in press."},{"key":"10.1016\/j.critrevonc.2010.01.005_bib8","series-title":"Urologic surgical pathology","first-page":"259","article-title":"Neoplasms of the urinary bladder","author":"Cheng","year":"2008"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-5347(17)68279-X","article-title":"Intra-urothelial cancer: carcinoma in situ, Bowens's disease of the urinary system: discussion of thirty cases","volume":"68","author":"Melicow","year":"1952","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-001-0577-6","article-title":"Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation","volume":"440","author":"Lopez-Beltran","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1442-2042.2008.02012.x","article-title":"Clinical outcomes of Bacillus Calmette-Guerin instillation therapy for carcinoma in situ of urinary bladder","volume":"15","author":"Takenaka","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1098-2388(199709\/10)13:5<291::AID-SSU2>3.0.CO;2-8","article-title":"Epidemiology and etiology of bladder cancer","volume":"13","author":"Johansson","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00345-003-0382-8","article-title":"The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review","volume":"21","author":"Zeegers","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1464-410X.2003.04523.x","article-title":"Cytopathological expression of different types of urothelial carcinoma in situ in urinary bladder washings","volume":"92","author":"Demir","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/pgmj.2006.050112","article-title":"Importance of red patches diagnosed in cystoscopy for haematuria and lower urinary tract symptoms","volume":"83","author":"Fernando","year":"2007","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2303.2007.00426.x","article-title":"Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses","volume":"18","author":"Garbar","year":"2007","journal-title":"Cytopathology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.eururo.2006.08.037","article-title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy","volume":"51","author":"Shariat","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.urology.2006.03.033","article-title":"Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy","volume":"68","author":"Shariat","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib19","first-page":"3849","article-title":"Effects of timing and type of tobacco in cigarette-induced bladder cancer","volume":"48","author":"Vineis","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib20","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2337::AID-CNCR23>3.0.CO;2-6","article-title":"Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder","volume":"86","author":"Fleshner","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/03008880802325192","article-title":"A meta-analysis on the association between bladder cancer and occupation","author":"Reulen","year":"2008","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1054\/bjoc.1999.1106","article-title":"Non-steroidal anti-inflammatory drugs and bladder cancer prevention","volume":"82","author":"Castelao","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib23","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/ijc.22546","article-title":"Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study","volume":"120","author":"Genkinger","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/03008880802325309","article-title":"Infection: is it a cause of bladder cancer?","author":"Abol-Enein","year":"2008","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.0.CO;2-A","article-title":"Flat intraepithelial lesions of the urinary bladder","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0022-5347(01)67650-X","article-title":"Carcinoma in situ of the bladder","volume":"153","author":"Hudson","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00428-002-0627-8","article-title":"The pagetoid variant of bladder urothelial carcinoma in situ: a clinicopathological study of 11 cases","volume":"441","author":"Lopez-Beltran","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.eururo.2003.11.019","article-title":"Biopsy of the red patch at cystoscopy: is it worthwhile?","volume":"45","author":"Swinn","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.eururo.2009.02.033","article-title":"A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications","volume":"56","author":"Cauberg","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2007.03.028","article-title":"A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study","volume":"178","author":"Fradet","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib31","first-page":"1003","article-title":"Photodynamic diagnosis for follow-up of carcinoma in situ of the bladder","volume":"3","author":"Colombo","year":"2007","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-5347(05)65963-0","article-title":"Clinical significance of denuded urothelium in bladder biopsy","volume":"166","author":"Levi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib33","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/ijc.21958","article-title":"Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder","volume":"119","author":"van Oers","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000478-200103000-00010","article-title":"Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00000478-200107000-00007","article-title":"In situ adenocarcinoma of the bladder","volume":"25","author":"Chan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00000478-199904000-00009","article-title":"Natural history of urothelial dysplasia of the bladder","volume":"23","author":"Cheng","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jcp.55.9.641","article-title":"Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer","volume":"55","author":"Lopez-Beltran","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.MP.0000056628.38714.5D","article-title":"Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia","volume":"16","author":"Mallofre","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2005.12.041","article-title":"The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma","volume":"50","author":"Schrier","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0090-4295(96)00624-3","article-title":"Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after Bacillus Calmette-Guerin treatment","volume":"49","author":"Ick","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib42","first-page":"655","article-title":"TP53 gene mutations as an independent marker for urinary bladder cancer progression","volume":"21","author":"Ecke","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.urolonc.2007.07.011","article-title":"Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study","volume":"26","author":"Salinas-Sanchez","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1309\/2TY6GTV1GQ6B5ARM","article-title":"Prognostic value of combined p53 and survivin in pT1G3 urothelial carcinoma of the bladder","volume":"129","author":"Gonzalez","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib45","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0090-4295(03)00236-X","article-title":"Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder","volume":"61","author":"Shariat","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(00)00892-X","article-title":"E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder","volume":"57","author":"Shariat","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib47","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/hupa.2002.127441","article-title":"E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma","volume":"33","author":"Sun","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib48","first-page":"784","article-title":"Two molecular pathways to transitional cell carcinoma of the bladder","volume":"54","author":"Spruck","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib49","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2217\/fon.09.50","article-title":"Molecular determinants of tumor recurrence in the urinary bladder","volume":"5","author":"Cheng","year":"2009","journal-title":"Future Oncol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib50","first-page":"809","article-title":"Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder","volume":"62","author":"Hartmann","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib51","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0002-9440(10)64388-X","article-title":"Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma","volume":"161","author":"Hopman","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib52","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/ijc.24619","article-title":"Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development","volume":"125","author":"Zieger","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib53","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/0008-5472.CAN-03-3620","article-title":"Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification","volume":"64","author":"Dyrskjot","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib54","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1158\/1078-0432.CCR-06-2940","article-title":"Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study","volume":"13","author":"Dyrskjot","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5489\/cuaj.600","article-title":"Biomarkers for detection and surveillance of bladder cancer","volume":"2","author":"Budman","year":"2008","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MOU.0b013e3282c8c72b","article-title":"Bladder cancer biomarkers: current developments and future implementation","volume":"17","author":"Alvarez","year":"2007","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib57","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/ijc.22238","article-title":"Urinary biomarker profiling in transitional cell carcinoma","volume":"119","author":"Munro","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2353\/ajpath.2006.050601","article-title":"Profiling bladder cancer using targeted antibody arrays","volume":"168","author":"Sanchez-Carbayo","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib59","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-5347(05)66428-2","article-title":"Current bladder tumor tests: does their projected utility fulfill clinical necessity?","volume":"165","author":"Lokeshwar","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib60","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0022-5347(05)65072-0","article-title":"A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine","volume":"167","author":"Halling","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib61","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMcp012694","article-title":"Clinical practice. Microscopic hematuria","volume":"348","author":"Cohen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib62","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0022-5347(05)67104-2","article-title":"A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma","volume":"164","author":"Halling","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib63","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.eururo.2007.11.051","article-title":"The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer","volume":"54","author":"Gudjonsson","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib64","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.eururo.2006.10.044","article-title":"UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer","volume":"51","author":"Moonen","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1309\/K5P2-4Y8B-7L5A-FAA9","article-title":"Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings","volume":"116","author":"Bubendorf","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib66","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0022-5347(05)64270-X","article-title":"Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer","volume":"168","author":"Sarosdy","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib67","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jcp.2007.049684","article-title":"Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions","volume":"61","author":"Schwarz","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib68","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/01.ju.0000173918.84006.4d","article-title":"Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States","volume":"174","author":"Messing","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib69","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/01.ju.0000134347.14643.ab","article-title":"A side by side comparison of cytology and biomarkers for bladder cancer detection","volume":"172","author":"Schroeder","year":"2004","journal-title":"J Urol"},{"issue":"Suppl. 2","key":"10.1016\/j.critrevonc.2010.01.005_bib70","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/modpathol.2008.193","article-title":"Diagnosis of urothelial carcinoma from urine","volume":"22","author":"Tetu","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib72","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2010.01.005_bib73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000475201","article-title":"BCG in perspective: advances in the treatment of superficial bladder cancer","volume":"27","author":"Lamm","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib74","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","article-title":"The treated natural history of high risk superficial bladder cancer: 15-year outcome","volume":"158","author":"Cookson","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib75","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1464-410X.1994.tb07549.x","article-title":"Intravesical Evans Bacille Calmette-Guerin for carcinoma in situ of the urinary bladder. Scottish Urological Oncology Group","volume":"73","author":"Talic","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib76","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance Bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib77","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0022-5347(05)66333-1","article-title":"Control group and maintenance treatment with Bacillus Calmette-Guerin for carcinoma in situ and\/or high grade bladder tumors","volume":"165","author":"Palou","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib78","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00345-009-0384-2","article-title":"Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working party","volume":"27","author":"Alfred Witjes","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib79","first-page":"281","article-title":"Bacillus Calmette-Gu\u00e9rin failures and beyond: contemporary management of non-muscle-invasive bladder cancer","volume":"10","author":"Grossman","year":"2008","journal-title":"Rev Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-5347(17)61913-X","article-title":"The plight of the patient with carcinoma in situ of the bladder","volume":"103","author":"Utz","year":"1970","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib81","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-4295(99)80047-8","article-title":"Risk factors in carcinoma in situ of the urinary bladder","volume":"45","author":"Van Gils-Gielen","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2007.06841.x","article-title":"Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments","volume":"100","author":"Sanderson","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib83","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0090-4295(96)00571-7","article-title":"Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management","volume":"49","author":"Solsona","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-5347(01)66433-4","article-title":"The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter","volume":"155","author":"Kenworthy","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib85","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0022-5347(05)68176-1","article-title":"Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation","volume":"162","author":"Balaji","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib86","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.juro.2007.01.133","article-title":"Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup","volume":"177","author":"Sanderson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib87","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000475308","article-title":"Significance of urethral carcinoma in situ in specimens of cystectomy","volume":"25","author":"Batista","year":"1994","journal-title":"Eur Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib88","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/cncr.22238","article-title":"Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer","volume":"107","author":"Raj","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib89","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-5347(01)64312-X","article-title":"Ureteral carcinoma in situ at radical cystectomy: does the margin matter?","volume":"158","author":"Silver","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib90","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.urology.2006.05.040","article-title":"Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tract","volume":"68","author":"Yuasa","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2010.01.005_bib91","unstructured":"Patel SG, Cookson MS, Barocas DA, Clark PE, Smith JAJ, Chang SS. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer. BJU Int; in press."},{"key":"10.1016\/j.critrevonc.2010.01.005_bib92","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jjco\/27.6.406","volume":"27","author":"Tobisu","year":"1997","journal-title":"Jpn J Clin Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T06:20:44Z","timestamp":1558765244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842810000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1040842810000065"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2010.01.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}